start portlet menu bar end portlet menu bar

Comparative study of the humoral immune responses developed by 5 commercial monovalent <i>Erysipelothrix rhusiopathiae</i> vaccines

Strona główna Wiedza Comparative study of the humoral immune responses developed by 5 commercial monovalent <i>Erysipelothrix rhusiopathiae</i> vaccines

Comparative study of the humoral immune responses developed by 5 commercial monovalent <i>Erysipelothrix rhusiopathiae</i> vaccines

The aim of this study was to compare the humoral immune responses elicited in naïve pigs by five different inactivated monovalent Erysipelothrix rhusiopathiae vaccines.

Pobierz ten artykuł

167 kB

O tym artykule

Opublikowano w

IPVS Congress, 2016

Autorzy

Camprodon, A.; Pedrazuela, R.; Torrents, D.

Streszczenie

In this study, the humoral immunity elicited by ERYSENG® was faster, higher and lasted longer than the humoral immune response developed by the other commercial vaccines. ERYSENG® provided the best humoral protection during the entire fattening period.

Powiązane usługi

HIPRA Diagnos

Powiązane produkty

ERYSENG®

Powiązane publikacje

Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines Farrowing parameters enhancement in two brazilian farms using ERYSENG® PARVO/LEPTO vaccine Comparative study of the humoral response against swine erysipelas induced by ERYSENG® PARVO and another commercial vaccine under field conditions in Germany

Udostępnij na

start portlet menu bar

Comparative study of the humoral immune responses developed by 5 commercial monovalent <i>Erysipelothrix rhusiopathiae</i> vaccines

Display portlet menu
end portlet menu bar

Patrz także

Publikacje

Intradermal application of vaccines in pigs (Poster)

04-10-2018
Streszczenia choroby

Edema disease

03-11-2017
Aktualności

HIPRA takes a step forward in Taiwan with the launch of UNISTRAIN® PRRS vaccine

11-10-2018